Sheldon N Crane

Title: Sheldon N. Crane: Innovator in Pharmaceutical Compounds

Introduction

Sheldon N. Crane is a notable inventor based in Pincourt, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds and methods for treating various medical conditions. With a total of two patents to his name, Crane's work is focused on innovative solutions that address critical health issues.

Latest Patents

Crane's latest patents include groundbreaking work on compounds and pharmaceutical compositions. One patent discloses compounds and pharmaceutically acceptable salts that may be used in the treatment of subjects in need thereof. These compounds are identified as inhibitors of tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1). Additionally, another patent focuses on compounds that serve as inhibitors of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR). Both patents also detail pharmaceutical compositions containing these compounds and methods for their preparation and use.

Career Highlights

Sheldon N. Crane is currently associated with Repare Therapeutics Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on improving patient outcomes through effective pharmaceutical solutions.

Collaborations

Crane collaborates with talented individuals in his field, including Vouy Linh Truong and Jean-François Truchon. These partnerships enhance the research and development process, fostering an environment of creativity and innovation.

Conclusion

Sheldon N. Crane is a distinguished inventor whose contributions to pharmaceutical compounds are paving the way for new treatment options. His patents reflect a deep understanding of complex biological processes and a dedication to improving healthcare.